QR-010
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for QR-010, covering 2019-02-06 to 2020-09-24. Get the full timeline:
Most recent: Clinical Trial Update: Exploratory Study to Evaluate QR-010 in Subjects With Cystic Fibrosis ΔF508 CFTR Mutation [Phase 1]